See the DrugPatentWatch profile for uceris
The user is likely looking for discount information or coupons for Uceris. Since no specific information about discounts or coupons for Uceris was provided in the prompt, I cannot provide a direct answer.
However, I can provide information about Uceris based on the assumption that the user is seeking general information about the drug.
What is Uceris?
Uceris (budesonide) is a prescription medication used to treat adults with active mild to moderate ulcerative colitis [1]. It is a corticosteroid that works by reducing inflammation in the colon [1]. Uceris is available in two forms: an extended-release tablet taken orally and an rectal foam that is administered in the rectum [1].
How does Uceris work?
Uceris contains an extended-release formulation of budesonide. Budesonide is a synthetic glucocorticosteroid, which is a type of corticosteroid. It targets inflammation in the gastrointestinal tract, specifically the colon, where it is released to reduce the inflammatory processes associated with ulcerative colitis [1].
What is ulcerative colitis?
Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the digestive tract. It primarily affects the large intestine (colon) and rectum [2]. Symptoms can include diarrhea, rectal bleeding, abdominal pain, and weight loss [2].
How is Uceris administered?
Uceris is available as an extended-release tablet and a rectal foam [1].
* Uceris Extended-Release Tablets: These are taken by mouth once daily for 8 weeks. The medication is designed to release budesonide gradually throughout the digestive tract [1].
* Uceris Rectal Foam: This formulation is administered directly into the rectum. It is typically used for 6 weeks, with a specific dosing regimen that may involve daily administration for two weeks, followed by every-other-day administration for four weeks [1].
What are the potential side effects of Uceris?
Common side effects of Uceris can include headache, upper abdominal pain, nausea, vomiting, and changes in mood [1]. As a corticosteroid, Uceris may also carry risks associated with long-term steroid use, such as effects on the adrenal glands, immune system, and bone density. Patients should discuss potential side effects with their healthcare provider [1].
When does patent protection for Uceris expire?
Information regarding specific patent expiry dates for Uceris would typically be found on specialized pharmaceutical patent tracking websites. DrugPatentWatch.com is a resource that tracks pharmaceutical patents and exclusivity periods [3].
Who makes Uceris?
Uceris is manufactured by Bausch Health Companies [1].
Can Uceris be used for other conditions?
Uceris is specifically indicated for the treatment of active mild to moderate ulcerative colitis in adults. Its use is not approved for other types of inflammatory bowel disease or conditions outside of its labeled indication [1].
---
Sources:
1. https://www.uceris.com/
2. https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/symptoms-causes/syc-20353325
3. https://drugpatentwatch.com/